Literature DB >> 30498721

Actively implementing enteral nutrition to reduce parenteral nutrition-associated liver disease.

Shuifang Jin1, Ronglin Jiang1, Weibin Ma2.   

Abstract

Entities:  

Year:  2018        PMID： 30498721      PMCID： PMC6230842          DOI： 10.21037/hbsn.2018.06.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

Review 1.  Changes to the Intestinal Microbiome With Parenteral Nutrition: Review of a Murine Model and Potential Clinical Implications.

Authors:  Farokh R Demehri; Meredith Barrett; Daniel H Teitelbaum
Journal:  Nutr Clin Pract       Date:  2015-09-30       Impact factor: 3.080

2.  Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure-Associated Liver Disease in Surgical Infants.

Authors:  Darla R Shores; Samuel M Alaish; Susan W Aucott; Janine E Bullard; Courtney Haney; Heidi Tymann; Bareng A S Nonyane; Kathleen B Schwarz
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

Review 3.  Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition.

Authors:  Gary P Zaloga
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-07-15       Impact factor: 4.016

4.  Greater Protein and Energy Intake May Be Associated With Improved Mortality in Higher Risk Critically Ill Patients: A Multicenter, Multinational Observational Study.

Authors:  Charlene Compher; Jesse Chittams; Therese Sammarco; Michele Nicolo; Daren K Heyland
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

5.  Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.

Authors:  Feng Shen; Rui-Dan Zheng; Xing-Qiang Sun; Wen-Jin Ding; Xiao-Ying Wang; Jian-Gao Fan
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2017-08-15

Review 6.  Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.

Authors:  Giuseppe Orso; Claudia Mandato; Claudio Veropalumbo; Nicola Cecchi; Alfredo Garzi; Pietro Vajro
Journal:  Dig Liver Dis       Date:  2015-11-14       Impact factor: 4.088

7.  Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the "modified NUTRIC" nutritional risk assessment tool.

Authors:  Adam Rahman; Rana M Hasan; Ravi Agarwala; Claudio Martin; Andrew G Day; Daren K Heyland
Journal:  Clin Nutr       Date:  2015-01-28       Impact factor: 7.324

8.  Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.

Authors:  Kiran V K Koelfat; Frank G Schaap; Caroline M J M Hodin; Ruben G J Visschers; Björn I Svavarsson; Martin Lenicek; Ronit Shiri-Sverdlov; Kaatje Lenaerts; Steven W M Olde Damink
Journal:  Clin Nutr       Date:  2016-09-24       Impact factor: 7.324

Review 9.  Liver Disease in Patients on Total Parenteral Nutrition.

Authors:  Arnab Mitra; Joseph Ahn
Journal:  Clin Liver Dis       Date:  2017-08-19       Impact factor: 6.126

10.  Reversal of intestinal failure-associated liver disease (IFALD): emphasis on its multifactorial nature.

Authors:  Christian Hvas; Kamelia Kodjabashia; Emma Nixon; Stephen Hayes; Kirstine Farrer; Arun Abraham; Simon Lal
Journal:  Frontline Gastroenterol       Date:  2015-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.